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Adenine nucleotide translocase
Regulation of adenine nucleotidesThe mitochondrial ATP-Mg/Pi carrier imports adenine nucleotides from the cytosol into the mitochondrial matrix
and exports phosphate. The carrier is regulated by the concentration of cytosolic calcium, altering the size of the
adenine nucleotide pool in the mitochondrial matrix in response to energetic demands. The protein consists of
three domains; (i) the N-terminal regulatory domain, which is formed of two pairs of fused calcium-binding EF-
hands, (ii) the C-terminal mitochondrial carrier domain, which is involved in transport, and (iii) a linker region
with an amphipathicα-helix of unknown function. Themechanismbywhich calciumbinding to the regulatory do-
mainmodulates substrate transport in the carrier domain has not been resolved. Here, we present two new crystal
structures of the regulatory domain of the human isoform 1. Careful analysis by SEC conﬁrmed that although the
regulatory domain crystallised as dimers, full-length ATP-Mg/Pi carrier is monomeric. Therefore, the ATP-Mg/Pi
carriermust have a differentmechanism of calcium regulation than the architecturally related aspartate/glutamate
carrier, which is dimeric. The structure showed that an amphipathicα-helix is bound to the regulatory domain in a
hydrophobic cleft of EF-hand 3/4. Detailed bioinformatics analyses of different EF-hand states indicate that upon
release of calcium, EF-hands close, meaning that the regulatory domain would release the amphipathic α-helix.
We propose a mechanism for ATP-Mg/Pi carriers in which the amphipathic α-helix becomes mobile upon release
of calcium and could block the transport of substrates across the mitochondrial inner membrane.
Crown Copyright © 2015 Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Themitochondrial ATP-Mg/Pi carrier (APC) is amember of themito-
chondrial carrier family of transport proteins. Mitochondrial carriers are
typically located in the mitochondrial inner membrane and fulﬁl the
vital role of shuttling nucleotides, amino acids, inorganic ions, keto
acids, fatty acids and cofactors between the mitochondrial matrix and
the cytosol [1]. APC is involved in the import of cytosolic adenine nucle-
otides into the mitochondrion and the export of inorganic phosphate
from the mitochondrial matrix [2–4]. Mitochondria also have ADP/ATP
carriers, a related but functionally distinctmember of themitochondrial
carrier family [5]. In contrast to APC, ADP/ATP carriers catalyse the equi-
molar exchange of ADP from the cytosol for ATP synthesised in the
mitochondrial matrix, meaning that their activity does not inﬂuence
the size of the adenine nucleotide pool [5]. The unequal exchange of
substrate catalysed by APC does have the potential to inﬂuence thecalcium binding mitochondrial
othreitol; EGTA, ethylene glycol
C, size exclusion chromatogra-
r B.V. This is an open access article utotal matrix adenine nucleotide pool. Therefore, APC has the important
role of altering the mitochondrial adenine nucleotide pool in order to
adapt to changing cellular energetic demands [6–8].
In yeast only oneAPC ortholog exists (Sal1p) [9], whereas in humans
four genes encode full-length APC paralogs; SLC25A24, SLC25A25,
SLC25A23 and SLC25A54 encoding for the protein short calcium binding
mitochondrial carrier (SCaMC) isoform 1 (APC-1), SCaMC-2 (APC-3),
SCaMC-3 (APC-2) and SCaMC-1L, respectively [3,10,11]. Another gene,
SLC25A41, encodes for SCaMC-3L protein [12], which is shorter in
sequence than the other APC isoforms (for a review see Satrústegui &
Pardo, 2007) [13]. Mitochondrial carriers are fundamental to cellular
metabolism, and have been implicated in many severe human diseases
[14]. There is experimental support for the notion that up-regulation of
human SCaMC-1 (HsAPC-1) expression in cancerous tissues may help
these cells to evade cell death [15].
APC has a three-domain structure. The N-terminal domain of APC
forms a calcium-sensitive regulatory domain [3,10]. The consequence
of calcium binding to the regulatory domain of APC is a stimulation of
the substrate transport activity of the carrier [2,4,7]. A structure of the
regulatory domain of human APC isoform-1 has recently been solved
[16], conﬁrming the presence of four EF-hands, each of which is occu-
pied by a bound calcium ion in a canonical pentagonal bi-pyramidal
fashion. The EF-hands group together into two pairs, forming twonder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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EF-hands of calmodulin [16].
The C-terminal domain of APC is a membrane protein with the
characteristic structural fold of mitochondrial carrier proteins [17]. The
carrier fold is composed of three repeats [18], each containing two
membrane-spanning α-helices connected by a matrix α-helix, making
a three-fold pseudo-symmetrical protein structure [19,20]. Atomic
structures of both bovine [19] and yeast ADP/ATP carriers [20] provide
the basis for our understanding of the structure/function relationship
between key sequence elements conserved across the carrier family.
Based on the identiﬁcation of a conserved central substrate binding
site [21] ﬂanked by two salt bridge networks on either side [22], an al-
ternating access mechanism has been proposed for substrate transport
through carrier proteins [20,22].
The linker region between the N-terminal regulatory domain and
the C-terminal carrier domain contains an amphipathic α-helix of un-
known function. In the structure this α-helix is bound to EF-hand pair
3 and 4, analogous to the binding of a calmodulin recognition sequence
motif to the hydrophobic pockets in the EF-hands of calmodulin [16].
Another member of the carrier family of proteins, the aspartate/
glutamate carrier (AGC), also displays a calcium-dependence for activity
and has an N-terminal regulatory domain that contains EF-hands.
Structures of both the calcium-bound and calcium-free states of the
regulatory domain of the human AGC have recently been solved [23].
The structures reveal eight EF-hand motifs, only one of which is in-
volved in calcium binding. Most mitochondrial carriers are monomeric
[24], but AGC was found to be dimeric [23]. EF-hands four to eight are
recruited to form an extensive interface for homo-dimerisation that
is critical for the observed calcium-induced conformational changes
within the regulatory domain of AGC [23]. Thus both APC and AGC
have N-terminal regulatory domains consisting of EF-hands. Although
no signiﬁcant sequence similarity exists between these regulatory do-
mains, there is the possibility that they share a common mechanism
of calcium-regulation, potentially based on a homo-dimer arrangement.
The protein construct used in the previous study of the HsAPC-1 regula-
tory domainwasmutated at the extremeN-terminus to replace a cyste-
ine residue at position 15with a serine [16], raising the possibility that a
native dimer could have been disrupted [25].
NMR nuclear Overhauser effects have shown that the regulatory do-
main of HsAPC-1 is more dynamic and less structured in the calcium-
free state [16]. Binding studies with surface plasma resonance have
indicated that the regulatory domain interacts with the carrier domain
in the absence of calcium [16]. A mechanism was proposed in which
the regulatory domain binds to the carrier domain in the absence of cal-
cium, capping it in order to block substrate transport [16], however that
mechanism does not explain why the bound calcium-free regulatory
domain would be more dynamic. Therefore, the mechanism that cou-
ples calcium binding in the regulatory domain to substrate transport
in the carrier domain has not been resolved.
Here, an independent structural determination of the native human
APC-1 regulatory domain was completed, whichwas combinedwith an
investigation into the oligomeric state of the full-length human APC-1
protein. Furthermore, an extensive comparison of the conformations
of EF-hand proteins in the calcium-free, calcium-bound and peptide-
bound state was undertaken, which has allowed us to propose a mech-
anism for the regulation of APC that is consistent with all available
experimental data.
2. Materials and methods
2.1. Expression and puriﬁcation of full-length HsAPC-1
A construct of HsAPC-1 (Uniprot: Q6NUK1) was designed to include
an eight-histidine tag followed by a Factor Xa cleavage site (IEGR) at the
N-terminus, creating a cleavable puriﬁcation-tag. The gene was codon-
optimized for expression in S. cerevisiae by GenScript and cloned intoa pYES3/CT expression plasmid (Invitrogen), with the inducible galac-
tose promoter being replaced by the constitutive promoter for the
yeast mitochondrial phosphate carrier, as described previously [26].
The expression plasmidwas transformed into S. cerevisiaehaploid strain
W303-1b [27], using established methods [28].
S. cerevisiae was cultured, and HsAPC-1 was expressed following
established methods [20], with the following modiﬁcations: pre-
cultures of yeast were set up in synthetic-complete tryptophan-dropout
medium (Formedium) supplemented with 2% glucose, and the main
cultures were carried out in an Applikon bioreactor with 100 L YEPDme-
dium.Mitochondria were prepared using establishedmethods [29], ﬂash
frozen in liquid nitrogen, and stored under liquid nitrogen until use.
HsAPC-1 was solubilised in lauryl maltose neopentyl glycol
(LMNG), and separated from insoluble protein by ultracentrifugation.
Solubilised protein was passed through nickel sepharose afﬁnity resin
(GE Healthcare) to selectively bind full-length HsAPC-1, and washed
with 50 column volumes of buffer A (20 mM Tris pH 7.4, 150 mM
NaCl, 20 mM Imidazole, 0.1% (w/v) LMNG, 0.1 mg mL−1 tetra-oleoyl
cardiolipin) and 30 column volumes of buffer B (20 mM Tris pH 7.4,
50 mM NaCl, 0.1% (w/v) LMNG, 0.1 mg mL−1 tetra-oleoyl cardiolipin).
Factor Xa protease (New England BioLabs) was used to speciﬁcally
cleave the HsAPC-1 protein from the afﬁnity resin. After Factor Xa cleav-
age, HsAPC-1 was spun through an empty Proteus midi-spin column
(Generon) to remove afﬁnity resin. Protein concentrations were deter-
mined using the bicinchoninic acid assay [30] against a bovine serum al-
bumin standard curve (Pierce). Puriﬁed protein was used immediately
for analysis using SEC.
2.2. Expression and puriﬁcation of HsAPC-1 regulatory domain
Primers were design in order to create a construct of HsAPC-1 to in-
clude just the regulatory domain and the linker region (residues 14 to
174) of the protein (Forward primer: GAAGGTAGAACCTCCGAAGA. Re-
verse primer: CCTAGGTCTAGACTCGAGTCATTATTATATATCAATACCTGT
GGAATGTTT). The inter-domain loopwas not included in this construct.
The construct was cloned into the Lactococcus lactis expression plasmid
pNZ8048, and the plasmid transformed into electrocompetent L. lactis
NZ9000 using established methods [31]. Expression of the construct
was carried out as described previously [23]. Puriﬁcation of HsAPC-1
was achieved using a three-step chromatography protocol. First, clari-
ﬁed L. lactis lysate was passed over Ni sepharose resin (GE Healthcare).
The resin was washed with 50 column volumes of puriﬁcation buffer
(20mMTris pH 7.5, 150mMNaCl, 1 mMDTT) containing 50mM imid-
azole and eluted in puriﬁcation buffer containing 250 mM imidazole.
Second, recovered protein was concentrated, and desalted using a
PD10 column (GE Healthcare). The puriﬁcation tag was removed from
the construct by digestion with Factor Xa protease (Supplementary
Fig. 1). Finally protein was loaded onto a Superdex 200 pg 16/60 SEC
column (GE Healthcare) in a running buffer of 20 mM Tris pH 7.5,
20mMNaCl. Peak fractions were collected and concentrated to approx-
imately 10 mg mL−1 for crystallography.
2.3. Experimental analysis of oligomeric state
Superdex 200 pg 16/60 SEC columns (GE Healthcare) were cali-
brated with molecular weight standards from both the high and low
molecular weight standards kits (GE Healthcare), and unknown protein
weights were estimated using the manufacturers recommended proto-
col. The SEC buffer used for analysis of the HsAPC-1 RD protein was
puriﬁcation buffer with either 5 mM calcium or 5 mM EGTA, with or
without 1 mM DTT added as stated. The SEC buffer used for analysis of
the full-length HsAPC-1 was 20 mM Tris pH 7.4, 50 mM NaCl, 0.03%
(w/v) LMNG and 0.03 mg mL−1 tetra-oleoyl cardiolipin. The buffers
used to run the molecular weight standards in each case matched the
buffers being used in the analysis of each protein.
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mass could be determined colorimetrically by sugar assay [32], phos-
phorus assay [33] and bicinchoninic acid assay [30], respectively. SDS-
PAGE gels for the analysis of full-length HsAPC-1 were composed of
12% acrylamide and run using a Tris–Glycine buffer system. SDS-PAGE
gels for the analysis of HsAPC-1 RD were composed of 10% acrylamide
and run using a Tris–Tricine buffer system. Gels were stained with
Imperial coomassie stain (Bio-Rad), and de-stained in water.
2.4. HsAPC-1 regulatory domain crystallisation, data collection and
structural determination
Crystallisation screening with puriﬁed HsAPC-1 RD yielded an ini-
tial hit in drop H4 of the JBS Classics screen (Jena Bioscience) with
a mother-liquor composed of 30% (w/v) polyethylene glycol 8000,
0.2M ammonium sulfate. Optimisation around this hit produced square
plate-like crystals in 29% (w/v) polyethylene glycol 8000, 0.2 M ammo-
nium sulfate, larger in both width and height than the original hit,
approximately 200 × 200 μm in dimension.
Crystals of a tetrahedral bi-pyramidalmorphology could be grown in
25–30% (w/v) polyethylene glycol 8000, 0.2 M lithium sulfate condi-
tions. These crystals were smaller than the square plate-like crystals,
with dimensions of about 40 × 30× 30 μm, and grew aswell deﬁned sin-
gle crystals.
High-resolution diffraction datasets were collected at Diamond
beamline I24 and ESRF beamline ID23-2 for the P2 and P212121 crystals,
respectively. A long-wavelength dataset of the P212121 crystals used for
a calcium-SAD experimentwas also collected at Diamond beamline I24.
Using the known HsAPC-1 RD structure as a molecular replacement
template [16] the structure of the HsAPC-1 RDwas solved in two differ-
ent space groups: to 2.1 Å resolution in space-group P2 from the square
plate-like crystals, and to 2.6 Å in the space-group P212121 from the tet-
rahedral bi-pyramidal type crystals. Reﬁnement statistics are shown in
(Table 1). High-resolution datasets were integrated using iMOSFLM
[34], followed by scaling and merging with POINTLESS and AIMLESSTable 1
HsAPC-1 regulatory domain structure reﬁnement statistics.
Space group P212121
4ZCV
Wavelength (Å) 1.002
Resolution range (Å) 40.10–2.80 (2.95–2.80)
Unit cell 75.92 77.01 119.90 90 90 90
Total reﬂections 57586
Unique reﬂections 17779
Multiplicity 3.2 (3.2)
Completeness (%) 99.6 (99.7)
Anomalous multiplicity –
Anomalous completeness (%) –
Anomalous signala –
Mean I/sigma(I) 8.4 (2.8)
Wilson B-factor 51.03
R-merge (%) 9.8 (40.0)
R-meas (%) 12.2 (53.7)
R-work 0.2110
R-free 0.2590
Number of non-hydrogen atoms 4859
Water molecules 50
Protein residues 599
Number of molecules per ASUb 4
RMS(bonds) 0.011
RMS(angles) 0.927
Ramachandran favoured (%) 97.5
Ramachandran outliers (%) 0
Clash score 8.66
Average B-factor 64
Statistics for the highest-resolution shell are shown in parentheses.
a Anomalous signal calculated by phenix.Xtriage.
b Asymmetric unit (ASU).
c Single wavelength anomalous dispersion (SAD).[35] in the CCP4 suite [36]. The long-wavelength dataset was processed
by the pipeline Xia2 [36] using 3D spot integration. For molecular re-
placement phenix.phaser within the PHENIX suite [37] of software was
used. After initial placement of molecular replacement models, 50
rounds of jelly body reﬁnement in REFMAC5 [36] were used to improve
phases before rounds of manual building and reﬁnement were under-
taken. Final rounds of reﬁnement were carried out using phenix.reﬁne
in the PHENIX suite [37] of software including the use of Translation/
Libration/Screw groups, selected using phenix.ﬁnd_TLS_groups.
The long-wavelength dataset was phased bymolecular replacement
with the reﬁned P212121 model using phenix.phaser. The anomalous
difference map was calculated using phenix.ﬁnd_peaks_and_holes.
Phasing by molecular replacement of the P2 dataset was originally
only successful in P1 as the space-group was initially assigned as P21.
The program ZANUDA in the CCP4 suite [36] was used to identify the
correct higher symmetry space-group as P2. For manual building of
the model into density the program COOT was used [38].
2.5. Structural interpretation and representation
All structures were visualised and diagrams prepared using PyMOL
(version 1.7.0.2) [39]. The program PISA in the CCP4 suite [36] was
used to evaluate the dimerisation interfaces of dimeric proteins in
Table 3. The solvent ﬁlled cavity was visualised using the surface view
mode in PyMOL [39] set to ‘cavities and pockets’, with surface cull set
to ‘47’, surface detection radius set to 5 solvent radii and surface cut-
off radius set to 4 solvent radii.
2.6. Comparison of EF-hand structures
Uniprot was used to search for structures of EF-hand proteins with
a Pfam [40] assignment of EF-hand 7 or EF-hand 8, which both indi-
cate pairs of EF-hands. Each EF-hand was superposed on EF-hand 1 of
calcium-bound calmodulin using 10 residues of the entering α-helix
to position 5 of the EF-hand loop. In total 129 EF-hands were alignedP2
4ZCU
P212121–Ca2+-SADc
0.873 1.823
39.39–2.1 (2.16–2.10) 40.40–4.35 (4.505–4.35)
76.08 47.02 93.24 90 108.5 90 375.76 77.63 121.17 90 90 90
118930 165332
36885 5031
3.2 (3.2) 32.9 (27.5)
99.67 (100.00) 99.7 (98.3)
– 17.9 (17.4)
– 99.8 (98.3)
– 0.1304
7.25 (1.47) 17.90 (5.94)
27.62 57.776
11.9 (95.8) 23.8 (102.8)
14.3 (115.3) 24.8 (105.9)
0.2364
0.2745
3922
168
454
3
0.0096
0.829
97.5
0.5
9.09
50
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the centre of both the entering and exiting α-helix, and the angle be-
tween the lines calculated. A histogram of all the angles was plotted
using Prism 5.0 (GraphPad) and a Gaussian distribution of the angles
each subset of EF-hands exhibit, were calculated.
2.7. Modelling calcium-free HsAPC-1
We propose α-helix 4/5 represents a static element connecting the
two lobes of the protein together. The pitch of the α-helix 4/5 allowed
precise manual alignment [39] of the calcium-free EF-hand pair models
independently of the position of the other α-helices of the calcium-
bound lobes of the HsAPC-1 RD structure. This process was repeated,
replacing both lobe 1 and 2 with each respective reference model.
Residues from the end of α-helix 8 onwards were excluded from the
models, as no reference for the position of the amphipathic α-helix in
the calcium-free state is available. The MODELLER [41] web-server was
then used to perform comparative protein structure modelling in order
to replace the residues of the reference structures with those of HsAPC-
1 RD. This approach included the use of spatial restraints and CHARMM
energy terms in order to preserve the proper stereochemistry, and an op-
timisation step using the variable target function method [42].
2.8. Author contributions
S.P.D.H. expressed, puriﬁed and crystallised proteins, performed bio-
chemical assays and carried out the structure determination. All authorsFig. 1. Features of the HsAPC-1 RD structure. A) A single chain of the HsAPC-1 regulatory doma
chains is superposed. Electron density from an anomalous difference Fourier map, calculated fro
phobic pockets 1 and 2 that bind the loop preceding the amphipathicα-helix and the amphipath
(black for calmodulin peptides or cyan for others) when EF-hands of other proteins are superp
the HsAPC-1 RDmolecule is shown, but in panels C and D a surface representation is used. In a
amphipathicα-helix is represented in red. Calcium ions are represented as lime green spheres,
are represented as sticks, and nitrogen and oxygen atoms are coloured according to conventiowere involved in experimental planning, data collection at synchro-
trons, data analysis and manuscript preparation.
2.9. Accession numbers
The coordinates and structure factors of the calcium-bound regula-
tory domain of the ATP-Mg/Pi carrier in both the P2 and P212121
forms have been deposited in the Protein Data Bank under accession
codes PDB ID: 4ZCU and PDB ID: 4ZCV, respectively.
3. Results and discussion
3.1. The HsAPC-1 regulatory domain structure
A construct of the regulatory domain (RD) and the linker region
(residues 14 to 174) of HsAPC-1 was expressed in L. lactis and puriﬁed.
HsAPC-1 RD was crystallised using sitting drop vapour diffusion tech-
niques, predominantly in two different conditions. Molecular replace-
ment using the recently solved structure of the HsAPC-1 RD (PDB ID:
4N5X) [16], yielded solutions, which were reﬁned to produce models
with good R-factors and geometry statistics in space-groups P212121
or P2 (Table 1).
As was found previously [16], the HsAPC-1 RD structure is formed
of two lobes connected by a long α-helix (helix 4/5) (Fig. 1A), with
each lobe composed of a pair of EF-hands. Furthermore, each EF-
hand displays an ‘open’ antiparallel arrangement of α-helices (in-
cluding EF-hand 4), equivalent to that of calcium-bound calmodulin
structures [43–47].in (RD) structure. B) Detailed views of the EF-hands where each observation in the seven
m the P212121 space-group, is displayed as a mesh in red (σ-level of 5). C) View of hydro-
icα-helix itself, respectively, or D) the position of calmodulin recognition sequencemotifs
osed on lobe 2 of the HsAPC-1 RD structure. In panels A and B a cartoon representation of
ll panels EF-hands 1 to 4 are coloured in purple, blue, yellow and orange respectively. The
and red spheres represent watermolecules. In all cases, where side chains are shown, they
n.
Table 2
Superposition of signal peptides with the amphipathic α-helix.
Protein Peptide
bound
PDB Residuesa EF-hands
RMSD
(Å)b
Peptide
RMSD
(Å)c
Reference
Calmodulin Rs20 1QS7 5–74 0.753 2.780 Unpublished
Calmodulin MLCK 2BBN 5–74 1.510 5.094 [53]
Calmodulin PMCA
R-domain
4AQR 5–74 1.113 9.631 [54]
Troponin C Troponin I 3TZ1 83–149 3.112 9.301 [55]
KCNIP1 Selfd 1S1E 123–170 0.163 11.403 [48]
GCAP1 Selfd 2R2I 86–129 0.419 9.665 [49]
Citrine Selfd 4P5W 12–87 0.959 12.062 [23]
Abbreviations: Myosin light chain kinase (MLCK), Calcium-transporting ATPase 8, Plasma
membrane type (PMCA), Kv channel interacting protein-1 (KCNIP1), Guanylate activating
protein 1 (GCAP1).
a EF-hands were aligned to residues 88–151 of the HsAPC-1 RD structure.
b RMSD calculated using the align function in PyMOL (version 1.7.0.2) and represents
the value after outlier rejection.
c RMSD calculated using rms_cur function in PyMOL (version 1.7.0.2) and represents
the value without superposition and without rejecting outliers.
d The α-helix with which the EF-hands are interacting is part of the same polypeptide
chain.
e Synonym for citrin is AGC-2.
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For four of the chains there was a break in electron density between
residues 139 and 141 (EF-hand 4), and calcium could only be modelled
into EF-hand 4 in the three chains of the P2 space group, but not the four
chains in the P212121 space-group (Fig. 1B). This is in contrast with the
previously solved structure, which showed calcium binding in all four
EF-hands [16].
Itwaspreviously suggested that an interaction between the terminal
amphipathicα-helix and the hydrophobic pocket of HsAPC-1 RDmight
be a crystallisation artefact [16]. Here we independently conﬁrm this
interaction (Fig. 1C), even though the expression, puriﬁcation and
crystallisation procedures, and the crystal packing was different. It was
previously noted that the interaction of the amphipathic α-helix with
pocket-2 mimics the binding of signal-peptides into the hydrophobic
pockets in calmodulin [16]. This analysis was extended (Table 2) by
superimposing structures of other α-helix binding EF-hand pairs onto
lobe 2 of HsAPC-1 RD independently of the bound α-helix. The boundFig. 2. Crystal packing of HsAPC-1 RD chains, and comparison to previous HsAPC-1 RD structure
another. Each dimer is represented as a cartoon and coloured according to B-factor values as i
labelled I and II respectively. B) The seven observed chains of the HsAPC-1 RD were superpose
by the RMSD difference from 4N5X as in the key. Calcium ions are represented as lime green sα-helix in each case matched the position of the amphipathic α-helix
well (Fig. 1D), with α-helices bound to calmodulin being most similar
in position (Table 2).We conclude that this interaction is not an artefact,
and propose that the amphipathic α-helix has a speciﬁc role in the
regulatory mechanism.
One unusual feature of the interaction between the hydrophobic
pocket and its target, the amphipathic α-helix, is that they are both
part of the same polypeptide chain. Other EF-hand proteins, such as cal-
modulin, interact with target α-helices of other proteins. However, the
APC regulatory domain is not unique in this type of ‘self-sequestered’
interaction. Other examples are Kv channel interacting protein-1
[48], Guanylate activating protein 1 [49], AGC [23], stroma interacting
molecule-1 [50], and Calcyphosin [51].
The interaction between regulatory domain and the amphipathic
α-helix resembles that of AGC and the C-terminal α-helix, and given
that they are both members of the mitochondrial carrier family of pro-
teins it is tempting to conclude that they might have an analogous
mechanism. However, a fundamental difference is that in AGC the car-
rier domain is inserted between the EF-hands and the target α-helix,
whereas in APC the target α-helix is inserted between the EF-hands
and the carrier domain.
3.2. Oligomeric state of HsAPC-1
In both crystal space-groups, HsAPC-1 RDwas crystallised as a paral-
lel homo-dimer (Fig. 2A). In the previous study, it was crystallised as a
monomer, but Cys15 was replaced by serine [16]. The dimer interface
is composed of the α-helices of the EF-hands (helices 1, 2, 3, 6, and 7),
and is focussed at two contact points, one point from each EF-hand
pair. All of the HsAPC-1 RD chains observed here differ slightly from
the previous HsAPC-1 RD structure (PDB ID: 4N5X) around α-helices 2
and 3 (Fig. 2B). These α-helices are involved in the ﬁrst contact point
of the dimerisation interface, which could explain these differences.
In total, between the two space groups, seven copies of the HsAPC-1
RDwere observed in this study. Each chain has a solvent accessible sur-
face area of approximately 8800 Å [36], of which 1400 Å [36] is buried
by the dimer interface. All seven copies can be superposed upon
one another with good agreement: RMSD 0.552 Å (±0.270 Å) over
all atoms in each chain. Furthermore, the dimers can also be superposed
with good agreement: RMSD 0.629 Å (±0.475 Å) over all atoms in each. A) Seven unique dimer combinations of HsAPC-1 RD in total were superposed upon one
ndicated in the key. The two main points of contact between each chain of the dimer are
d on the previously published one (PDB ID: 4N5X). The structures in panel B are coloured
pheres.
Table 3
Comparison of dimerisation interfaces in EF-hand containing proteins.
Protein PDB code Monomer or dimer
in solution
Surface of monomer (Å2) Surface area buried
by dimerization
hydrogen bonds salt-bridges Solvation energy gain
(kcal mol−1)
(Å2) (%)
HsAPC-1 RD 4ZCV – 8716 1394 16 4 0 −16.6
Calmodulin 1CLL Monomer 9721.0 612.4 6 2 4 1.0
Calcyphosin 3E3R Monomer 11376.8 824.5 7 7 0 −7.5
Recoverin 1REC Monomer/dimer 9565 1060 11 9 1 −13.9
Neurocalcin 1BJF Monomer/dimer 10554 1161 11 8 4 −9.5
AGC RD 4P5W Dimer 15719 2242 14 15 2 −22.0
S100A15 4AQI Dimer 6248 1136 18 13 0 −21.3
Calpain 1DVI Dimer 10781 2085 19 20 1 −21.8
Crystal contacts 2–5% in all cases.
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two space groups, even though they are packed very differently.
One of the contact points of dimerisation involves the calcium-
binding loop of EF-hand 4, a site that had notably high B-factors and
poor electron density (Fig. 2A). Between the two contact points there
is a large solvent-ﬁlled cavity. In comparison to structures of proteins
with proven dimerisation interfaces, the two chains of HsAPC-1 bury a
comparable surface area, however the theoretical solvation energy
gain was more comparable to that of recoverin or neurocalcin that
have an interface for transient dimerisation (Table 3). The interface
between HsAPC-1 protomers contains relatively few hydrogen bonds
and no salt-bridge interactions, which is more comparable to theFig. 3. Full-length HsAPC-1 is monomeric. A) SEC trace for full-length HsAPC-1 and protein qua
total mass. C) SEC trace for crudely isolated HsAPC-1 RD. Peak 1 was found to contain a contam
complex (Supplementary Fig. 1). In panels A and C the elution volume of molecular weight stan
the peaks 2 and 3 run on an SDS-PAGE gel in the presence or absence of DTT.crystal contacts observed between chains of calmodulin or calcyphosin
(Table 3).
To clarify this issue further, an independent experimental analysis of
the oligomeric state of the HsAPC-1 was conducted, ﬁrst on the full-
length HsAPC-1 (Fig. 3). The protein was expressed in yeast, solubilised
in LMNG, puriﬁed and analysed by size exclusion chromatography
(SEC) (Fig. 3A). Compared to molecular weight standards, the total
mass of the HsAPC-1 protein:detergent:lipid micelle was 223.5 kDa.
An experimental assessment of the individual contributions to the
total mass revealed that 153.2 kDa could be attributed to detergent,
18.7 kDa could be attributed to lipid, with the remaining mass,
51.2 kDa, being attributed to protein. Full-length HsAPC-1 has antiﬁcation by SDS-PAGE gel (inset). B) Contributions of protein, detergent and lipid to the
inant, and identiﬁed as the 56.1 kDa E2 component of the L. lactis pyruvate dehydrogenase
dards are indicated and annotated with the mass of the standard. D) Protein from each of
Fig. 4. Calcium-induced conformational changes in EF-hands. Views of 129 EF-hands
superposed on EF-hand 1 of calcium-bound calmodulin, in the calcium-free (A–C) and
calcium-bound (D–F) states. Entering and exiting α-helices are represented as a line
though theα-helix centre. G) A histogram of the angles between the entering and exiting
α-helices of conventional (not S100-like) EF-hands.
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tein is monomeric in detergent (Fig. 3B).
Next the oligomeric state of the isolated HsAPC-1 RD construct was
investigated. During puriﬁcation, two dominant peaks with retention
volumes of 85 mL and 94.5 mL were observed in SEC traces (peak 2
and peak 3) (Fig. 3C). By SDS-PAGE analysis combined with peptide
mass ﬁngerprinting, both peaks 2 and 3 were found to contain HsAPC-
1 RD (Supplementary Fig. 1). The theoretical mass of the HsAPC-1 RD
protein construct is 21 kDa. The estimatedmolecular weight of the pro-
tein in peak 2 (56 kDa) corresponds to the theoretical mass of a regula-
tory domain dimer, and peak 3 (28 kDa) is consistentwith themass of a
monomer (Supplementary Fig. 2).
It was important to determinewhether the observed dimerisation of
the isolated RD could be inﬂuenced by calcium. Fractions from peak 2
and peak 3were pooled separately, and analysed by SEC in the presence
of calcium or ethylene glycol tetraacetic acid (EGTA), and with or
without the reducing agent dithiothreitol (DTT). The elution volumes
of the dimer and monomer species were both affected (Table 4 and
Supplementary Fig. 2), but the shift in estimated size between the two
conditions was not enough to account for the difference between a
monomer and a dimer.
The addition of the reducing agent DTT caused the protein in peak 2
to shift in size closer to themass expected for themonomeric species in
both calcium and EGTA conditions (Table 4 and Supplementary Fig. 2).
Therefore, dimerisation appears to be caused by disulphide bond for-
mation between proteins (Fig. 3D), and is not inﬂuenced by calcium
binding (Table 4 and Supplementary Fig. 2). The cysteine residue in
the HsAPC-1 RD sequence (Cys15) that is involved in the disulphide
bond is not conserved in other APC orthologs (Supplementary Fig. 3).
To conclude; (i) the dimerisation interface between the two chains
of HsAPC-1 does not conform to expected characteristics for a physi-
ologically relevant dimer, (ii) the cysteine involved in covalent
dimerisation is not conserved and (iii) no effect of calciumondisulphide
bond formation could be observed. Therefore, APC is monomeric and
dimers of the HsAPC-1 RD observed in SEC traces and in crystal struc-
tures appear to be caused by non-speciﬁc disulphide bond formation
between Cys15 residues and by crystal packing, respectively. Thus the
mechanism of calcium regulation of transport must be different from
that of AGC, which is dimeric.
3.3. Modelling conformational changes in the HsAPC-1 regulatory domain
TheHsAPC-1 RDhas been solved in a calcium-bound state. However,
to appreciate themechanismbywhich the regulatory domainwould in-
ﬂuence substrate transport, the calcium-free state must also be investi-
gated. Even though attempts have beenmade here and previously [16],
it was not possible to obtain crystal hits in the presence of EGTA. Instead
structures of other EF-hand proteinswithin the PDBwere studied to de-
rive the most likely conformational change in the absence of calcium.
A diverse reference set of EF-hand containing proteins was selected
from the PDBwith a preference for those containing EF-hands organised
in pairs. Both crystal structures and NMRmodels of calcium-bound and
calcium-free states were selected (Supplementary Table 1). In total,
over 100 EF-hands were structurally superposed.Table 4
Oligomeric state of HsAPC-1 RD under different conditions.
Original
oligomeric
state
Conditions of second
SEC column
Elution
volume
(mL)
Estimated
molecular
weight (kDa)
Oligomeric state
after second SEC
column
Ca2+ EGTA DTT
Monomer ✓ 93.8 25 Monomer
Dimer ✓ 84.8 51 Dimer
Dimer ✓ ✓ 93.8 25 Monomer
Monomer ✓ 90.3 34 Monomer
Dimer ✓ 79.3 80 Dimer
Dimer ✓ ✓ 90.3 34 MonomerCalcium-bound EF-hands displayed open or semi-open conforma-
tions. The angle of the exiting α-helix relative to the entering α-helix
was 70° to 90° and 55° to 70°, respectively (Fig. 4). Calcium-free EF-
hands displayed generally a closed conformation (45° to 65°). These
results agree with a previous study [52], but expand the reference set
to include a larger number of EF-hands published since the previous
study was conducted.
The largest variations were seen for the S100-like EF-hands, which
have an additional two residues in the calcium-binding loop, and
therefore provide a wider variety of possible conformations of the
exiting α-helix. Some of the EF-hands within AGC are S100-like, but
all four EF-hands of HsAPC-1 are conventional EF-hands, and adopt
the fully open conformation as expected for calcium-bound EF-hands
(Fig. 4 and Supplementary Table 1).
In order to understand the conformational changes that occur when
HsAPC-1 goes from the calcium-bound to the calcium-free state, models
of the calcium-free state were generated based on deposited structures.
Three models of known calcium-free EF-hand pairs (with conventional
EF-hand motifs) were chosen as reference structures for modelling;
centrin (PDB ID: 1ZMZ)with an angle of ~40°, N-terminal lobe of calmod-
ulin (PDB ID: 1CFD) with an angle of ~55° and the N-terminal lobe of
calcium-dependent protein kinase (PDB ID: 3HZT) with an angle of ~65°.
Although the three resultingmodels had some structural differences
from one another, the general motion that they described was
Fig. 5.Amodel for the calcium regulation ofHsAPC-1 RD. A) Threemodels for calcium-freeHsAPC-1 RDbased on centrin (model-1), calmodulin (model-2) and calcium-dependent protein
kinase (model-3) were superposed onto the calcium-bound HsAPC-1 RD structure and coloured cyan, magenta and green respectively. The calcium-bound HsAPC-1 structure is coloured
by RMSDdifference from the calcium-freemodels as in the key. B) A close up viewof hydrophobic pocket 2 intowhich the amphipathicα-helix (red) is bound. The calcium-boundHsAPC-
1 RD structure is shown as a surface representation and coloured blue, whereas the superposed calcium-free models are represented as cartoon (coloured as in panel A). C) The proposed
regulatory mechanism between calcium-bound state of HsAPC-1 where the carrier is active and the calcium-free state of HsAPC-1 where the carrier is inactive. The calcium-free model
presented in panel C is based on model 2. α-helices are represented as cylinders in panel C. Calcium ions are presented as lime green spheres.
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7 adopt a position thatwould prevent the binding of the amphipathicα-
helix to hydrophobic pocket 2 (Fig. 5B). Therefore, in the absence
of calcium, the hydrophobic pockets of HsAPC-1 RD close, and as a
consequence the amphipathic α-helix is excluded (Supplementary
video 1). All three models agree with this mechanism, but model 2
is preferred, as it represents the median of calcium-free EF-hand
structures (Fig. 4G). In support of this mechanism, the isolated APC
regulatory domain becomes more dynamic in the absence of calcium,
particularly in the region of the amphipathic α-helix as demonstrated
by nuclear Overhauser effect experiments [16]. Furthermore, we dem-
onstrate here using SEC that under calcium-free condition the hydrody-
namic radius of the isolated APC regulatory domain is increased in
comparison with the calcium-bound state (Table 4), consistent with
the exclusion of the amphipathic α-helix from the pocket.
It is possible that when the amphipathic α-helix is released, it could
interact with the carrier domain to inhibit substrate transport, either by
blocking access to the binding site or by preventing conformational
changes required for transport by the carrier domain (Fig. 5D). This
model for the mechanism has more consistent features with an EF-
handmechanism than the “capping and uncapping”mechanism, previ-
ously proposed [16].
4. Conclusion
The evidence presented here indicates that the functional unit of
APC, including the isolated regulatory domain, is amonomer. Therefore,
APC differs from AGC, which has a regulatory mechanism based on con-
formational changes within a dimeric regulatory domain. Thus they
must be different in the key functional elements involved in regulation.Importantly, any mechanism for calcium regulation of transport must
be based on APC functioning as a monomer.
So far only structures of the calcium-bound state have been solved
(Fig. 1) [16], but it was possible to propose a model for the calcium-free
state based on known structures of calcium-free EF-hand pairs (Fig. 5).
We propose a conformational change in the HsAPC-1 RD where the am-
phipathicα-helix fulﬁls a role similar to that of a calmodulin recognition
sequence motif, even though it is part of the same protein. We propose
that upon the removal of calcium, the EF-hands close, leading to displace-
ment of the amphipathicα-helix from the hydrophobic pocket. Once re-
leased, the amphipathicα-helix would be in an ideal position to interact
with the carrier domain and block transport of substrates.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbabio.2015.07.002.
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